MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mineralys Therapeutics (MLYS) Earnings Date & Reports

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone... Show more

A.I. Advisor
published Earnings

MLYS is expected to report earnings to rise 80.77% to -93 cents per share on March 18

Mineralys Therapeutics MLYS Stock Earnings Reports
Q4'25
Est.
$-0.94
Q3'25
Beat
by $0.44
Q2'25
Beat
by $0.40
Q1'25
Beat
by $0.29
Q4'24
Missed
by $0.27
The last earnings report on November 10 showed earnings per share of -51 cents, beating the estimate of -95 cents. With 665.23K shares outstanding, the current market capitalization sits at 2.96B.
View a ticker or compare two or three
MLYS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MLYS showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com